brain health

  • DATABASE (345)

  • ARTICLES (210)

    • DATABASE (345)
    • ARTICLES (210)
  • Sort by
    • Relevance
    • Date

After disrupting Portugal’s public healthcare system with video consultations via app, Knokcare is offering its SaaS services to health insurers in Europe and beyond.

Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.

Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas. 

Based in San Francisco, Slow Ventures was founded in 2011 by an early Facebook employee David Morin, who helped to build the Facebook Platform and Facebook Connect. Slow Ventures is no longer known as the “Facebook Alumni Fund”.Today, the VC is a generalist fund, investing in diverse sectors worldwide, ranging from digital health to enterprise solutions. The firm has backed unicorn startups in the US like Postmates, Nextdoor, AngelList and Evernote. A fourth fundraising round has been launched for two new funds totaling $220m: seed funding of $165m and $55m for a follow-up round. Its last funding round closed at $145m in 2016.

Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.

Founded in 2020 in Boulder, Colorado, Trailhead Capital is a specialist agtech and foodtech investor that focuses on startups in the US, Canada, Australia and Israel. The VC’s regenerative agriculture portfolio includes investments in food ingredients traceability, food supply chains, reducing food waste and soil health environmental management.Recent investments include in the $12m Series A round of Vence, a US-based producer of virtual fencing wearables for livestock management in May 2021. In February 2021, it also participated in the $6m funding round of foodtech HowGood that specializes in rating the sustainability of grocery products.

Xu Hanhan graduated from the Guanghua School of Management, Peking University, in 2008. She then worked at the VC, China Renaissance Capital Investment, and later became personal assistant to ByteDance CEO and founder Zhang Yiming during the startup's early years. She co-founded Waterdrop in 2016 and is now in charge of Waterdrop Crowdfunding. She also started another of Waterdrop's platforms, Waterdrop Public Wellness, which helps charitable organizations fundraise as well as report on the usage of the funds received. 

Sanchez is a computer and data science expert with a master’s degree in innovation and research in informatics with specialization in advanced computing from the Polytechnic University of Barcelona (UPC). He also holds multiple certifications from the John Hopkins University School of Education. Sanchez is currently CTO and co-founder of HumanITcare, a telemedicine platform for remote patient monitoring using real-world data and AI to treat patients affected by chronic diseases and also to accelerate drug development and clinical trials. Prior to HumanITcare, Sanchez worked as Data Scientist in a joint-project between the Spanish insurance company Catalana Occidente and technology consultancy Raona to develop a sales collaborative platform. He has also worked on projects in software development, mobile apps, server and hardware as well as prototyping for IoT devices in the fields of education, health and wellness.

Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.

Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007.  Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics. 

Dimas Prasetyo is the founder and CEO of PesanLab. He graduated with a degree in Medical Technology and Laboratory Science from Yogyakarta Health Polytechnic. He has over eight years of work experience in marketing, operations and management in the clinical laboratory diagnostics industry. He was also a product specialist at Non-invasive Genetic Abnormalities Test in Your Clinic and at Natera Inc. He co-founded Lab Panorama Bandung in 2009 and left in 2013 to become the founder of LabConX that was later rebranded as PesanLab.

Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.

Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution. 

C4 Ventures was founded by Pascal Cagni, former VP and GM of Apple EMEIA. With offices in Paris and London, the firm invests in early-stage startups across market segments in Europe. The VC also supports later-stage companies interested in expanding into Europe. It currently has 33 startups in its portfolio with principal interests in sectors like hardware, digital media and the future of commerce and work.Recent investments in 2021 include the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed in August and the $5m seed round in June of Norbert Health, the French producers of the first ambient scanner that can measure vital signs.

Igor Martret dedicated 15 years of his life to professional sports. The former athlete, from the University of Barcelona, is passionate about ultra trails, marathons and triathlons. The sports performance advocate also worked for five years as club manager at Virgin Health and Holmes Place.In 2006, he joined the family business as COO of Drivania Chauffeurs that was started by his brothers in 2001. Today, he's co-owner and CEO of Drivania International, the family-run chauffeur services enterprise that has grown to become a leading chauffeur company in Europe. In 2016, the Martrets established on-demand shuttle services company Shotl.

Sorry, we couldn’t find any matches for “brain health”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.